Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in: European Surgery 4/2013

01.08.2013 | Original Article

Quality of life in type 2 diabetics with gastroesophageal reflux disease: a case control study

verfasst von: R. Promberger, A. Spitzer, J. Ott, J. Lenglinger, W. Eilenberg, M. Gadenstätter, C. Neumayer

Erschienen in: European Surgery | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Summary

Background

To compare health- and disease-related quality of life (QoL) in patients with gastroesophageal reflux disease (GERD), with and without type 2 diabetes mellitus (T2DM).

Methods

In a retro-pro study of 29 non-diabetic and 30 diabetic GERD-patients who underwent complete esophageal testing because of GERD symptoms, three different QoL questionnaires [short-form 36 (SF-36) questionnaire, Gastrointestinal Quality of Life Index (GIQLI), GERD-health related QoL Index (GERD-HRQL)] and a standardized symptom questionnaire were analyzed.

Results

T2DM patients revealed higher body-mass-index levels (31.8 ± 6.3 vs. 28.2 ± 4.4 kg/m2, p = 0.004), whereas hiatal hernias were found less frequently in non-diabetics (82.8 vs. 32.1 %, p < 0.001). Lower esophageal sphincter pressures (LES) were higher in T2DM GERD-patients (11.1 ± 6.1 vs. 5.3 ± 4.0 mmHg; p < 0.001). In the SF-36 domains, “vitality” and “physical functioning,” T2DM patients revealed lower QoL (48.8 ± 20.3 vs. 60.0 ± 16.7, p = 0.023; and 64.7 ± 25.4 vs. 78.8 ± 19.8, p = 0.027; respectively). The GERD-HRQL (16.8 ± 13.1 vs. 18.8 ± 10.7, p > 0.05) and GIQLI (88.5 ± 25.1 vs. 94.0 ± 18.2, p  > 0.05) did not differ significantly.

Conclusions

T2DM had a major impact on health-related QoL in patients with proven GERD, with impairment of the SF-36 domains, “physical functioning” and “vitality”. GERD-specific QoL, however, was similar in diabetic and non-diabetic patients.
Vorheriger Artikel Tissue engineering of vascular grafts
Nächster Artikel Impact of tumor location on prognosis in patients with thoracic esophageal squamous cell carcinoma
Literatur
1.
Vakil N, Zanten SV van, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.PubMedCrossRef
2.
Provenzale D. Epidemiology of gastroesophageal reflux disease. In: Orlando RC, editor. Gastroesophageal reflux disease. New York: Dekker; 2000. pp. 85–99.
3.
Gadenstätter M, Wykypiel H, Schwab GP, Profanter C, Wetscher G. Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: A comparison of medical and surgical therapy. Langenbecks Arch Surg. 1999;38:563–7.CrossRef
4.
Promberger R, Gadenstätter M, Ciovica R, Schwab G, Neumayer C. Gastroesophageal reflux disease in diabetic patients: a systematic review. Eur Surg. 2007;39:340–54.CrossRef
5.
Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275–85.
6.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef
7.
Virally M, Blickle JF, Girard J, Halimi S, Simon D, Guillausseau PJ. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab. 2007;33:231–44.PubMedCrossRef
8.
Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001;49:66–72.PubMedCrossRef
9.
Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14:709–12.PubMedCrossRef
10.
Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastroesophageal reflux disease. Gut. 2009;58:174–81.
11.
Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–65.
12.
Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastroesophageal reflux disease) in type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diab Med. 2009;26:228–33.
13.
Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res. 2005;14:21–33.PubMedCrossRef
14.
Kamolz T, Pointner R. Quality of life-a factor of medical outcome in surgery. Acta Chir Austriaca. 1998;30:355–9.CrossRef
15.
Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastroesophageal reflux disease—an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18:767–76.
16.
Velanovich V. Quality of life and severity of symptoms in gastroesophageal reflux disease: a clinical review. Eur J Surg. 2000;166:516–25.PubMedCrossRef
17.
Ronkainen J, Aro P, Storskrubb T, et al. Gastroesophageal reflux symptoms and health related quality of life in the adult general population—the Kalixanda study. Aliment Pharmacol Ther. 2006;23:1725–33.
18.
Kamolz T, Granderath F, Pointner R. Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett’s esophagus. Surg Endosc. 2003;17:880–5.PubMedCrossRef
19.
Kamolz T, Granderath FA, Schweiger UM, Pointner R. Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome. Surg Endosc. 2005;19:494–500.PubMedCrossRef
20.
Schunk M, Reitmeir P, Schipf S, et al. Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabetes Med. 2012;29:646–53.
21.
Sikdar KC, Wang PP, MacDonald D, Gadag VG. Diabetes and its impact on health related quality of life: a life table analysis. Qual Life Res. 2010;19:781–7.PubMedCrossRef
22.
Clouet F, Excler-Cavailher G, Christophe B, Masson F, Fasquel D. Type 2 diabetes and short-form 36-items Health Survey. Diabetes Metab. 2001;27:711–7.PubMed
23.
Chittleborough CR, Baldock KL, Taylor AW, Phillips PJ. Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Qual Life Res. 2006;15:687–94.PubMedCrossRef
24.
Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96:71–6.
25.
Hall JC, Hall JL. Emergence of †retropro’ studies in the surgical literature. ANZ J Surg. 2008;78:411–3.PubMedCrossRef
26.
American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006;29:S4–42.
27.
Ciovica R, Gadenstätter M, Klingler A, Lechner W, Riedl O, Schwab GP. Quality of life in GERD patients: medical treatment versus antireflux surgery. J Gastrointest Surg. 2006;10:934–9.
28.
Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. BJS. 1995;82:216–22.
29.
Velanovich V, Vallance SR. Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217–24.PubMed
30.
Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen:Hogrefe-Verlag; 1998.
31.
Ollyo JB, Fontolliet C, Lang BF. La nouvelle classification de Savary des oesophagites de reflux. Acta Endoscopica. 1992;22:307–20.CrossRef
32.
Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, “carditis’’, and Barrett’s esophagus and sequelae of therapy. Am J Surg Pathol. 1996;20:S31–50.PubMedCrossRef
33.
Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155:104–11.PubMedCrossRef
34.
DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thor Cardiovasc Surg. 1980;79:656–70.
35.
Hershcovici T, Jha LK, Gadam R, et al. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. J Clin Gastroenterol. 2012;46:662–8.
36.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.PubMedCrossRef
37.
Festi D, Scaioli E, Baldi F, et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol. 2009;15:1690–701.
38.
39.
Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterol. 2005;129:1825–31.
40.
Wex T, Mönkemüller K, Stahr A, et al. Gastroesophageal reflux disease is associated with up-regulation of desmosomal components in esophageal mucosa. Histopathol. 2012;60:405–15.
41.
Kandulski A, Wex T, Mönkemüller K, et al. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2010;105:1934–43.
42.
Choi CW, Kim GH, Song CS, et al. Is obesity associated with gastropharyngeal reflux disease? World J Gastroenterol. 2008;14:265–71.
43.
Neumayer C, Ciovica R, Gadenstätter M, et al. Significant weight loss after laparoscopic Nissen fundoplication. Surg Endosc. 2005;19:15–20.
44.
Norris SL, McNally TK, Zhang X, et al. Published norms under estimate the health-related quality of life among persons with type 2 diabetes. J Clin Epidemiol. 2011;64:358–65.
45.
Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13:283–98.
46.
47.
Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ. 2011;37:347–55.PubMedCrossRef
48.
Mezuk B, Eaton W, Albrecht S, Hill Golden S. Depression and type 2 diabetes over the life span. A meta-analysis. Diabetes Care. 2008;31:2383–90.PubMedCrossRef
49.
Kinekawa F, Kubo F, Matsuda K, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008;43:338–44.
50.
Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. The American Surgeon. 1998;64:649–53.PubMed
51.
Iyer PG, Borah BJ, Heien HC, et al. Association of Barrett’s esophagus with type II diabetes mellitus: results from a Large Population-Based Case Control Study. Clin Gastroenterol Hepatol. 2013. doi:10.1016/j.cgh.2013.03.024.
Metadaten
Titel
Quality of life in type 2 diabetics with gastroesophageal reflux disease: a case control study
verfasst von
R. Promberger
A. Spitzer
J. Ott
J. Lenglinger
W. Eilenberg
M. Gadenstätter
C. Neumayer
Publikationsdatum
01.08.2013
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2013
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-013-0219-7

Weitere Artikel der Ausgabe 4/2013

European Surgery 4/2013 Zur Ausgabe

Review

Tissue engineering of vascular grafts

Case Report

Hot airflow burn injury in a paraplegic patient: report of a case

Original Article

Impact of tumor location on prognosis in patients with thoracic esophageal squamous cell carcinoma

Short Communication

Pseudoangiomatous stromal hyperplasia of excised breast tissue associated with gynecomastia in juvenile and adolescent males

Editorial

Lessons learnt from the esophagogastric junction: the hidden counts

Original Article

Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents